Across TCGA pan-cancer cohorts, MIR4673 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR4673’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR4673 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4673 is over-expressed in tumor.
STAD and ESCA are the cancer types where MIR4673 tumor–normal differential expression is most reproducible.